Diagnosis of COVID-19 with simultaneous accurate prediction of cardiac abnormalities from chest computed tomographic images

PLoS One. 2023 Dec 14;18(12):e0290494. doi: 10.1371/journal.pone.0290494. eCollection 2023.

Abstract

COVID-19 has potential consequences on the pulmonary and cardiovascular health of millions of infected people worldwide. Chest computed tomographic (CT) imaging has remained the first line of diagnosis for individuals infected with SARS-CoV-2. However, differentiating COVID-19 from other types of pneumonia and predicting associated cardiovascular complications from the same chest-CT images have remained challenging. In this study, we have first used transfer learning method to distinguish COVID-19 from other pneumonia and healthy cases with 99.2% accuracy. Next, we have developed another CNN-based deep learning approach to automatically predict the risk of cardiovascular disease (CVD) in COVID-19 patients compared to the normal subjects with 97.97% accuracy. Our model was further validated against cardiac CT-based markers including cardiac thoracic ratio (CTR), pulmonary artery to aorta ratio (PA/A), and presence of calcified plaque. Thus, we successfully demonstrate that CT-based deep learning algorithms can be employed as a dual screening diagnostic tool to diagnose COVID-19 and differentiate it from other pneumonia, and also predicts CVD risk associated with COVID-19 infection.

MeSH terms

  • COVID-19 Testing
  • COVID-19* / diagnostic imaging
  • Deep Learning*
  • Heart Defects, Congenital*
  • Humans
  • Pneumonia*
  • SARS-CoV-2
  • Tomography, X-Ray Computed / methods

Grants and funding

This research was funded partially by Congressionally Directed Medical Research Program (CDMRP), University of Maryland School of Medicine, University of Maryland Baltimore County and The Pennsylvania State University.